123 related articles for article (PubMed ID: 1231726)
21. Effect of O-(beta-hydroxyethyl)-rutoside on the glucose metabolism of cultured human varicose saphenous veins.
Matagne D; Gilles R
Arch Int Physiol Biochim; 1977 Feb; 85(1):133-8. PubMed ID: 68718
[TBL] [Abstract][Full Text] [Related]
22. Effect of Venoruton on the factor XIII activity in rat plasma.
Grochal M; Sempińska-Edelberg E; Plewiński J
Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
[TBL] [Abstract][Full Text] [Related]
23. The effect of O-(beta-hydroxyethyl)-rutoside (HR) on macromolecular leakage, thrombosis and haemostasis in experimental animals.
Bergqvist D; Svensjö E; Arfors KE
Ups J Med Sci; 1978; 83(2):123-7. PubMed ID: 664118
[TBL] [Abstract][Full Text] [Related]
24. Studies on the haemolytic action of amphiphilic substances in vitro. Inhibition by O-(beta-hydroxyethyl)-rutosides.
Biesendorfer H; Felix W; Wildenauer DB
Biochem Pharmacol; 1981 Aug; 30(16):2287-92. PubMed ID: 7295341
[No Abstract] [Full Text] [Related]
25. [Do troxerutin and sodium rutin sulfate still possess the properties of rutin?].
Brasseur T; Angenot L; Pincemail J; Deby C
Ann Pharm Fr; 1987; 45(4):329-34. PubMed ID: 3445996
[No Abstract] [Full Text] [Related]
26. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography.
Forconi S; Guerrini M; Di Perri T
Vasa; 1977; 6(3):279-84. PubMed ID: 335696
[No Abstract] [Full Text] [Related]
27. The flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside is able to protect endothelial cells by a direct antioxidant effect.
Lemmens KJ; van de Wier B; Vaes N; Ghosh M; van Zandvoort MA; van der Vijgh WJ; Bast A; Haenen GR
Toxicol In Vitro; 2014 Jun; 28(4):538-43. PubMed ID: 24412621
[TBL] [Abstract][Full Text] [Related]
28. [Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside].
Agolini G; Cavallini GM
Clin Ter; 1987 Jan; 120(2):101-10. PubMed ID: 2972438
[No Abstract] [Full Text] [Related]
29. Spectrophotofluorometric analysis of 3',4',7-tris[O-(beta-hydroxyethyl)]rutoside in urine.
Tan HS; Mowery PJ; Ritschel WA; Neu C
J Pharm Sci; 1978 Aug; 67(8):1142-4. PubMed ID: 671254
[TBL] [Abstract][Full Text] [Related]
30. No effect of O-(beta-hydroxyethyl)-rutoside on red cell filterability in patients with acute myocardial infarction.
Waldenlind L; Edlund BL; Hulting J; Lund F
J Intern Med; 1990 Dec; 228(6):655-6. PubMed ID: 2280245
[No Abstract] [Full Text] [Related]
31. Rutoside and the X-ray induced damage in jejunal mucosa of mouse.
Rao KR; Fritz-Niggli H
Strahlentherapie; 1984 Oct; 160(10):624-6. PubMed ID: 6388050
[TBL] [Abstract][Full Text] [Related]
32. [Chromatographic studies of four water-soluble rutosides].
Geissler VG
Arzneimittelforschung; 1975 Apr; 25(4):511-6. PubMed ID: 1174068
[TBL] [Abstract][Full Text] [Related]
33. [Prevention of radiation-induced skin reactions in breast cancer].
Pischnamazzadeh M
Strahlentherapie; 1983 Jan; 159(1):9-12. PubMed ID: 6340249
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the hematological profile in rat following whole body gamma radiation with and without venoruton pretreatment.
Kanwar KC; Verma A
J Environ Pathol Toxicol Oncol; 1992; 11(4):235-9. PubMed ID: 1507075
[TBL] [Abstract][Full Text] [Related]
35. Effects of Troxerutin on the hemorheological parameters of patients with moderate arterial hypertension.
Gueguen-Duchesne M; Durand F; Le Goff MC; Genetet B
Prog Clin Biol Res; 1988; 280():401-6. PubMed ID: 3174703
[No Abstract] [Full Text] [Related]
36. Anticatatonic effect of venoruton.
Aley KO; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
[TBL] [Abstract][Full Text] [Related]
37. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
[No Abstract] [Full Text] [Related]
38. [Dose-response study with O-(beta-hydroxyethyl)-rutoside oral solution].
Nocker W; Diebschlag W
Vasa; 1987; 16(4):365-9. PubMed ID: 3321740
[No Abstract] [Full Text] [Related]
39. [Hemorrheology in clinical practice. Applications in an in vitro study of troxerutin].
Stoltz JF; Donner M
Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):200-5. PubMed ID: 1767174
[TBL] [Abstract][Full Text] [Related]
40. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency].
Barbarino C; Pezzangora V
Vasa Suppl; 1989; 27():120. PubMed ID: 2623482
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
